The Validation of New Photographic Technology for Assessing Skin Lesions

Validation of New Photographic Technology for Assessing Skin Lesions

NCT06663241•Wright State University

Summary

The purpose of this study is to determine the validity of a new photographic technology in a dermatologic setting. The digital picture uses high levels of resolution to look at skin biopsy lesions. These photos will be compared to current standard-of-care with hematoxylin and eosin histologic analysis by board-certified dermatologists.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Adult patients ages 18 and older.
•Able to comprehend procedures, risks, and informed consent.
•Have a skin lesion the practitioner believes, and subject agrees, should be biopsied.
•Lesion on a non-revealing part of the body (none on areas that would be recognizable, nor on groin nor breasts).
•Willingness of subject to share the results of the biopsy pathology.

Exclusion Criteria

•Lesion on a revealing part of body.
•Unable to understand the procedures, informed consent.

Locations (1)

Wright State Physicians

Fairborn, Ohio, United States

Key Dates

Start Date

February 15, 2023

Primary Completion Date

December 20, 2023

Completion Date

December 20, 2023

Last Updated

February 6, 2025

Enrollment

200

ACTUAL participants

Conditions

Skin Lesions

Evaluation of the EF192B Protection Versus No Treatment

NCT06752460

Skin LesionsSkin Care

View study

COMPLETEDPHASE1/PHASE2

Allogeneic Platelet Rich Plasma (PRP) to Treat Diabetic Foot Ulcers

NCT06680856

Diabetic Foot UlcerSkin Lesions+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 6, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

The Validation of New Photographic Technology for Assessing Skin Lesions

Inclusion Criteria

Exclusion Criteria

Evaluation of the EF192B Protection Versus No Treatment

Allogeneic Platelet Rich Plasma (PRP) to Treat Diabetic Foot Ulcers

To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Secondarily Infected Traumatic Skin Lesions

Dermoscopy in Diagnosis of Pigmentary Skin Lesions